This unique mechanism induces a synergistic outcome with enhanced insulin reaction and glucagonostatic activity, compared to GIP or GLP-1 therapy by itself. Summary Tirzepatide is a different molecule capable of controlling glucose blood degrees by combining the dual agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. GIP https://bathsalts08631.collectblogs.com/73706592/article-under-review